Back to Search
Start Over
Prognostic Value of Systemic Inflammatory Response Markers in Patients Undergoing Neoadjuvant Chemotherapy and Gastrectomy for Advanced Gastric Cancer in the Eastern European Population.
- Source :
-
Cancers . Apr2022, Vol. 14 Issue 8, p1997. 12p. - Publication Year :
- 2022
-
Abstract
- Simple Summary: This study aimed to verify the prognostic value of neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) in GC patients undergoing neoadjuvant chemotherapy (NAC) and gastrectomy. Elevated NLR and PLR prior to NAC were associated with significantly higher risk of death (mOS: 36 vs. 87 months; HR = 2.21; p = 0.0255 and mOS: 30 vs. 87 months; HR = 2.89; p = 0.0034, respectively). Additionally, a significantly higher risk of death was observed in patients with elevated NLR after NAC (mOS: 35 vs. 87 months; HR = 1.94; p = 0.0368). Selected systemic inflammatory response markers (NLR, PLR) are significant prognostic factors in patients with advanced GC treated with NAC and gastrectomy, as shown in the Eastern European population. The prognostic value of the systemic inflammatory response markers, namely neutrophil-to-lymphocyte ratio (NLR), lymphocyte-to-monocyte ratio (LMR), and platelet-to-lymphocyte ratio (PLR) has not yet been clarified in patients undergoing neoadjuvant chemotherapy (NAC) and gastrectomy for advanced gastric cancer (GC) in the Eastern European population. This study aimed to verify the prognostic value of NLR, PLR, and LMR in GC patients undergoing multimodal treatment. One hundred six GC patients undergoing NAC and gastrectomy between 2012 and 2020 were included. Analysed blood samples were obtained prior to NAC (pre-NAC group) and before surgical treatment (post-NAC group). To evaluate the prognostic value of the NLR, LMR, and PLR, univariable and multivariable overall survival (OS) analyses were performed. In the pre-NAC group, elevated NLR and PLR were associated with significantly higher risk of death (mOS: 36 vs. 87 months; HR = 2.21; p = 0.0255 and mOS: 30 vs. 87 months; HR = 2.89; p = 0.0034, respectively). Additionally, a significantly higher risk of death was observed in patients with elevated NLR in the post-NAC group (mOS: 35 vs. 87 months; HR = 1.94; p = 0.0368). Selected systemic inflammatory response markers (NLR, PLR) are significant prognostic factors in patients with advanced GC treated with NAC and gastrectomy, as shown in the Eastern European population. [ABSTRACT FROM AUTHOR]
- Subjects :
- *STOMACH tumors
*KRUSKAL-Wallis Test
*EAST Europeans
*PLATELET lymphocyte ratio
*ANALYSIS of variance
*CANCER chemotherapy
*MULTIVARIATE analysis
*LOG-rank test
*BLOOD collection
*MANN Whitney U Test
*GASTRECTOMY
*NEUTROPHIL lymphocyte ratio
*SURVIVAL analysis (Biometry)
*STATISTICAL hypothesis testing
*KAPLAN-Meier estimator
*TUMOR markers
*COMBINED modality therapy
*RECEIVER operating characteristic curves
*MONOCYTE lymphocyte ratio
*PROPORTIONAL hazards models
Subjects
Details
- Language :
- English
- ISSN :
- 20726694
- Volume :
- 14
- Issue :
- 8
- Database :
- Academic Search Index
- Journal :
- Cancers
- Publication Type :
- Academic Journal
- Accession number :
- 156504697
- Full Text :
- https://doi.org/10.3390/cancers14081997